Clinical characterization and molecular mechanisms of statin myopathy.

Abstract excerpt

Myopathy has been reported in a small percentage of statin-treated patients for the past 30 years, but the etiologic mechanisms for inducing muscle injury have not yet been fully characterized. Statin-induced myopathy is now understood to be a heterogeneous condition that may be due to: mechanisms of the drug itself; interactions with other drugs; or genetic, metabolic and immunological vulnerabilities in...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Autoimmune Diseases
• Share to Clinical Trials as Topic
• Share to Drug Interactions